Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Influenza “Histone Mimic” Suppresses Antiviral Response

16.03.2012
A team of researchers led by scientists at The Rockefeller University has identified a novel mechanism by which influenza interferes with antiviral host response.

The finding, reported in this week’s issue of the journal Nature, shows that the immunosuppressive NS1 protein of the influenza A virus hijacks key regulators of antiviral gene function by mimicking a core component of gene regulating machinery. The results they describe have major implications for our understanding of the biology of seasonal influenza virus and its pathogenesis. This research also suggests a possible target for a new class of antiviral and anti-inflammatory drugs.

The researchers, led by Alexander Tarakhovsky, head of the Laboratory of Immune Cell Epigenetics and Signaling, showed that the NS1 protein of the H3N2 influenza -- the most common strain circulating each flu season -- contains the same sequence of amino acids as the “tail” domain of a DNA packaging protein in humans called histone H3. The histones are present in the cell nucleus and play an important role in gene activation. Chemical modifications of the histone ”tails” allow recruitment of effector proteins that, in turn, determine which genes are switched on or off. Chemical modifications of histones were first identified by Rockefeller scientist Vincent G. Allfrey in the early 1960s. Decades later, Rockefeller University’s C. David Allis proposed the ”histone code” theory that describes the importance of histone tails in regulating a wide array of cellular functions.

“By mimicking the histone H3 tail, the NS1 tail gives the virus access to the core of gene regulating machinery,” says first author Ivan Marazzi, a postdoctoral fellow in the Tarakhovsky lab. “Through this mimicry the virus targets a set of proteins in the nucleus of the infected cells and impairs the anti-viral host cell response.”

Marazzi, together with graduate student Jessica Ho, discovered the ability of NS1 protein to track and target a protein complex called PAF1C, which has been previously studied extensively by Robert G. Roeder’s lab at Rockefeller. Together with Roeder’s lab, the Tarakhovsky lab revealed the ability of NS1 to interfere with the activity of PAF1 complex. This complex turned out to be essential for the expression of the genes that are responsible for antiviral response.

“NS1 is hijacking PAF1C and using its similarity with the H3 ‘tail’ to gain access to a position in the genome that helps the virus to block antiviral genes,” says Ho. “This finding extends the known ability of pathogens to reveal key regulatory processes and to use them for the pathogen’s advantage.”

The current study bears several major implications for influenza research and treatment. The NS1 protein varies from strain to strain. The ”tail” of NS1 appears to be one of the most diverse parts of the NS1 protein. Some flu strains such as H1N1, which was responsible for the 2009 pandemic, do not contain an NS1 “tail” at all. Together with their collaborator, prominent flu researcher Adolfo Garcia-Sastre of Mount Sinai School of Medicine, the Tarakhovsky lab plans to test if diversification of the NS1 “tail” helps the influenza virus to maintain a long-term presence within the human or animal populations. It is also puzzling how the influenza virus, which has no history of integration into animal or human DNA, has “learned” about the functional benefits of the histone “tail.”

Finally, by identifying PAF1C as a NS1 target, the researchers may have found a promising new target for attenuation of inflammatory responses. In collaboration with GlaxoSmithKline, previous efforts of the Tarakhovsky lab in this direction yielded a synthetic “histone mimic” called I-BET. By binding to BET proteins that control inflammatory gene expression, I-BET suppresses inflammation. I-BET and the related compound JQ1, which has been identified by Jay Bradner at the Dana-Farber Cancer Institute at Harvard Medical School, are now considered a new generation of so called “epigenetic” drugs, i.e., drugs that control DNA function without interfering with it directly.

The current discovery is proof and validation of the functional importance of “histone mimicry,” a phenomenon that was first discovered by Srihari Sampath, a Rockefeller M.D.-P.hD. student in Tarakhovsky’s lab. “I was always fascinated by mimicry and even brought an aquarium to my office with the hope of studying mimicry in fish,” says Tarakhovsky. “The aquarium experiment did not work well, but I am glad that I was helped by the flu.”

Joseph Bonner | Newswise Science News
Further information:
http://www.rockefeller.edu

More articles from Health and Medicine:

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

nachricht Highly precise wiring in the Cerebral Cortex
21.09.2017 | Max-Planck-Institut für Hirnforschung

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Comet or asteroid? Hubble discovers that a unique object is a binary

21.09.2017 | Physics and Astronomy

Cnidarians remotely control bacteria

21.09.2017 | Life Sciences

Monitoring the heart's mitochondria to predict cardiac arrest?

21.09.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>